GlassScriptPhysician profile
Roy Wesley Jones
NPI 1245650183
$43,347.36
in general payments reported to CMS, 2019-2025
25 companies · $16K in 2025
The $16K reported for 2025 was more than what 94% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,032 · 2020: $1,531 · 2021: $1,859 · 2022: $4,318 · 2023: $2,622 · 2024: $14K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $13K · Food and Beverage: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $12,705.94 |
| Food and Beverage | $11,301.20 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $14,328.97 | 2021-2025 | Indigo System, Penumbra System |
| Medtronic, INC. | $11,768.48 | 2023-2025 | Endurant Iis, Ellipsys Vascular Access System, Valiant Captivia |
| Silk Road Medical, INC. | $4,045.99 | 2020-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Medtronic Vascular, INC. | $2,095.17 | 2019-2020 | |
| Inari Medical, INC. | $1,748.36 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $1,495.84 | 2020-2025 | Eluvia, Embold Fibered, Enroute Transcarotid Neuroprotection System |
| W. L. Gore & Associates, INC. | $1,442.26 | 2021-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Shockwave Medical, INC | $1,184.83 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher |
| Philips North America LLC | $1,171.72 | 2020-2025 | (Bh4) Igt Devices Undivided, Igt Devices Undivided, (Br5) Peripheral Ivus |
| Cook Medical LLC | $1,010.68 | 2020-2025 | Zilver Ptx, Cook, Cook Celect |
| Cardiovascular Systems INC. | $945.40 | 2020-2022 | |
| Bard Peripheral Vascular, INC. | $371.73 | 2021-2023 | Venovo |
| Abbott Laboratories | $360.77 | 2024-2025 | Esprit, Jeti Peripheral Catheter, Supera |
| Neuros Medical, INC. | $354.84 | 2025 | Altius |
| Angiodynamics, INC. | $177.44 | 2023-2025 | Auryon Laser System 100-120 Vac |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $168.54 | 2025 | Inthrill Thrombectomy Catheter, Artix Mt, Flowtriever |
| Bolton Medical INC | $166.36 | 2025 | Treo Abdominal Stent-Graft System |
| Artivion, INC. | $155.72 | 2021-2024 | Bioglue Surgical Adhesive, Vascular, Photofix Decellularized Bovine Pericardium |
| Acera Surgical, INC. | $134.14 | 2023 | Restrata Wound Matrix |
| Terumo Medical Corporation | $71.67 | 2025 | R2p Misago |
| Axogen | $45.22 | 2024 | Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector |
| Cashflow Solutions, LLC | $33.94 | 2024-2025 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Lemaitre Vascular, INC. | $28.94 | 2025 | Artegraft Vascular Graft |
| Cardiva Medical, INC. | $28.31 | 2022 | |
| Pfizer INC. | $12.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.